XIFIN and OmniSYS Bridge Lab and Pharmacy

XIFIN’S ACQUISITION OF OMNISYS WILL UNITE LAB WITH PHARMACY

Acquisition is response to growing trend of retail pharmacies offering clinical services to consumers

This is an excerpt of a 1,829-word article in the January 10, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group.

CEO SUMMARY: XIFIN’s acquisition of OmniSYS, a pharmacy technology company, is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacists while also helping retail pharmacies with clinical service billing and reimbursement needs as they develop primary care clinics in their stores.

Read the excerpt article at The Dark Report

Share this article

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on email
Email

MORE TO EXPLORE